0001179110-18-013361.txt : 20181203
0001179110-18-013361.hdr.sgml : 20181203
20181203160652
ACCESSION NUMBER: 0001179110-18-013361
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181129
FILED AS OF DATE: 20181203
DATE AS OF CHANGE: 20181203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simonian Nancy A
CENTRAL INDEX KEY: 0001359574
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37813
FILM NUMBER: 181214080
MAIL ADDRESS:
STREET 1: C/O SYROS PHARMACEUTICALS, INC.
STREET 2: 620 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001556263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453772460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 620 MEMORIAL DRIVE
STREET 2: SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-744-1340
MAIL ADDRESS:
STREET 1: 620 MEMORIAL DRIVE
STREET 2: SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: LS22, Inc.
DATE OF NAME CHANGE: 20120815
4
1
edgar.xml
FORM 4 -
X0306
4
2018-11-29
0
0001556263
Syros Pharmaceuticals, Inc.
SYRS
0001359574
Simonian Nancy A
C/O SYROS PHARMACEUTICALS, INC.
620 MEMORIAL DRIVE, SUITE 300
CAMBRIDGE
MA
02139
1
1
0
0
President & CEO
Common Stock
2018-11-29
4
M
0
98504
1.01
A
469204
D
Common Stock
2018-11-29
4
M
0
12084
3.04
A
481288
D
Stock Option (right to buy)
1.01
2018-11-29
4
M
0
23454
0
A
2023-05-21
Common Stock
23454
872657
D
Stock Option (right to buy)
1.01
2018-11-29
4
M
0
75050
0
A
2023-05-21
Common Stock
75050
797607
D
Stock Option (right to buy)
3.04
2018-11-29
4
M
0
12084
0
A
2024-10-21
Common Stock
12084
785523
D
This option is fully vested.
/s/ Nancy Simonian
2018-12-03